Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Rimonabant attenuates amphetamine sensitisation in a CCK2 receptor-dependent manner

Rünkorg, K., Orav, L., Kõks, S., Matsui, T., Volke, V. and Vasar, E. (2012) Rimonabant attenuates amphetamine sensitisation in a CCK2 receptor-dependent manner. Behavioural Brain Research, 226 (1). pp. 335-339.

Link to Published Version:
*Subscription may be required


In this behavioural and pharmacological study in male CCK2 receptor-deficient mice (CCK2−/−), we evaluated the role of the interaction of endocannabinoids (eCBs) and cholecystokinin (CCK) on the regulation of anxiety-related and motor behaviours. Repeated treatment with amphetamine (2 mg/kg daily for four days) induced slightly weaker motor sensitisation in CCK2−/− mice compared to their wild-type (CCK2+/+) littermates. Co-administration of rimonabant (1 mg/kg) with amphetamine antagonised the development of motor sensitisation in CCK2+/+ mice. However, we did not find a similar effect of rimonabant in CCK2−/− mice. We did not find any differences between the behaviour of CCK2+/+ and CCK2−/− mice in models designed to assess emotional behaviours (dark/light exploration, marble burying and conditioned place aversion). This study supports the hypothesis that eCBs play a role in the development of amphetamine-induced sensitisation. Moreover, we have demonstrated that intact CCK2 receptors are necessary for the development of eCB-mediated sensitisation to amphetamine.

Item Type: Journal Article
Publisher: Elsevier B.V.
Copyright: © 2011 Elsevier B.V.
Item Control Page Item Control Page